Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous paracetamol versus intrathecal meperidine for prevention of shivering after spinal anesthesia in cesarean section
IRCT20240221061070N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postanesthetic shivering (PAS) comparing Intravenous paracetamol, Intrathecal meperidine and Placebo normal saline control (3 arms). Primary endpoint: Incidence and severity of shivering up to 90 minutes after spinal anesthesia. Started Apr 2025; status: completed.
02
Drugs
acetaminophenpethidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20240221061070N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240221061070N5.